A controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agents-Reference-Cited by-同舟云学术

A controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agents

Published:1999-07 Issue:1 Volume:84 Page:46-50
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Pepine Carl J,Wolff Andrew A

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference10 articles.

1. Pharmacological profile of ranolazine, a metabolic modulator active in ischaemia;Brown;Br J Pharmacol,1988

2. Protective effects of ranolazine in guineapig hearts during low flow ischemia and their association with increases in active pyruvate dehydrogenase;Clarke;Br J Pharmacol,1993

3. Ranolazine increases active pyruvate dehydrogenase in perfused normoxic rat hearts;Clarke;J Mol Cell Cardiol,1996

4. Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts;McCormack;Circulation,1996

5. Prevention of myocardial enzyme release by ranolazine in a primate model of ischaemia with reperfusion;Allely;Br J Pharmacol,1990

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review on the synthesis of substituted piperazine and its novel bio-medicinal applications;Chemistry of Inorganic Materials;2024-04

2. Effects of ranolazine on various outcomes in patients with stable angina: an updated meta-analysis;Hellenic Journal of Cardiology;2022-12

3. Role of ranolazine in heart failure: From cellular to clinic perspective;European Journal of Pharmacology;2022-03

4. Stereoselective quantitative analysis of ranolazine in plasma and tissue samples: application in pharmacokinetics and tissue distribution studies;New Journal of Chemistry;2022

5. Pharmacokinetics and Safety of Extended-release Ranolazine in Korean and White Healthy Subjects;Clinical Therapeutics;2021-03